EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines

Disease-relevant human induced pluripotent stem cells (iPSCs) are generated worldwide for research purposes; however, without robust and practical ethical, legal, and quality standards, there is a high risk that their true potential will not be realized. Best practices for tissue procurement, iPSC r...

Descripción completa

Detalles Bibliográficos
Autores principales: Steeg, Rachel, Mueller, Sabine C., Mah, Nancy, Holst, Bjørn, Cabrera-Socorro, Alfredo, Stacey, Glyn N., De Sousa, Paul A., Courtney, Aidan, Zimmermann, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365092/
https://www.ncbi.nlm.nih.gov/pubmed/34380020
http://dx.doi.org/10.1016/j.stemcr.2021.07.009
Descripción
Sumario:Disease-relevant human induced pluripotent stem cells (iPSCs) are generated worldwide for research purposes; however, without robust and practical ethical, legal, and quality standards, there is a high risk that their true potential will not be realized. Best practices for tissue procurement, iPSC reprogramming, day-to-day cultivation, quality control, and data management aligned with an ethical and legal framework must be included into daily operations to ensure their promise is maximized. Here we discuss key learning experiences from 7 years of operating the European Bank for induced Pluripotent Stem Cells (EBiSC) and recommend how to incorporate solutions into a daily management framework.

Ejemplares similares